About Adial Pharmaceuticals, Inc - Common Stock (ADIL)
Adial Pharmaceuticals Inc is a biopharmaceutical company focused on developing innovative therapies for the treatment of addiction and related disorders. The company is primarily engaged in the research and clinical development of its lead product candidate, which aims to reduce the risk of relapse in patients with alcohol use disorder. Adial utilizes a patient population-centric approach to address significant unmet medical needs in substance use disorders through its proprietary technology and scientific expertise. By leveraging partnerships and conducting clinical trials, Adial is committed to advancing solutions that improve the lives of individuals affected by addiction. Read More
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Friday. Let's explore the market movements and identify the stocks with significant gaps.
The US market is yet to commence its session on Friday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Mobix Labs, Inc. (NASDAQ: MOBX) has launched an unsolicited, non-binding proposal to acquire Peraso Inc. (NASDAQ: PRSO) in a stock-for-stock deal offering Peraso shareholders a 20% premium over the company’s 30-day average share price.
Wondering how the US markets performed one hour before the close of the markets on Thursday? Discover the movers and shakers of today's session in our comprehensive analysis.
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Intrigued by the market activity one hour before the close of the markets on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
